Delivery Systems for Biologics

Significant research and development interest exists in developing less-invasive or non-invasive routes for the systemic delivery of biologics, including subcutaneous, transdermal, oral, inhalation, nasal and buccal routes. This webinar will look at the current status, latest updates and future prospects for innovative delivery of peptides, proteins and other biologics.